Screener
LB Pharmaceuticals Inc LBRX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by LB Pharmaceuticals Inc in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: LB Pharmaceuticals Inc’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219607
FAQ
- What is LB Pharmaceuticals Inc's EPS (diluted)?
- LB Pharmaceuticals Inc (LBRX) reported EPS (diluted) of -$0.67 in Q1 2026.
- How has LB Pharmaceuticals Inc's EPS (diluted) changed year-over-year?
- LB Pharmaceuticals Inc's EPS (diluted) increased by 95.5% year-over-year, from -$14.79 to -$0.67.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about LB Pharmaceuticals Inc's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude